10

CSPC Pharmaceutical Group LtdHKG 1093 Stock Report

Last reporting period 30 Jun, 2024

Updated 05 Nov, 2024

Last price

Market cap $B

7.948

Middle

Exchange

XHKG - Hong Kong Exchange

1093.HK Stock Analysis

10

Uncovered

CSPC Pharmaceutical Group Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

94/100

Moderate score

Market cap $B

7.948

Dividend yield

8.64 %

Shares outstanding

11 916.44 B

CSPC Pharmaceutical Group Ltd. is an investment holding company, which is engaged in the manufacturing and selling of pharmaceutical products. The company is headquartered in Shijiazhuang, Hebei and currently employs 24,746 full-time employees. The firm sells its products under the brand of CSPS. The firm has four business segments: Finished Drugs, Antibiotics (intermediates and bulk drugs), Vitamin C (bulk drugs) and Caffeine and Others (bulk drugs). All these segments are engaged in the manufacture and sales of related pharmaceutical products. The finished drugs include the antibiotics, cardio-cerebrovascular drugs, diabetes drugs, neurology drugs, oncology drugs and traditional Chinese medicines. The firm is also engaged in the provision of pharmaceutical research and development services, as well as the processing of sewage and pharmaceutical by-products through its subsidiaries.

View Section: Eyestock Rating